Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CBFB | Q13951 | 12/20 | 1.00 |
| ▸ | METAP2 | P50579 | 8/20 | 1.00 |
| ▸ | METAP1 | P53582 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 5/20 | 0.97 |
| ▸ | RAB9A | P51151 | 5/20 | 0.97 |
| ▸ | PKM | P14618 | 4/20 | 0.97 |
| ▸ | LMNA | P02545 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | RUNX1 | Q01196 | 1/20 | 0.68 |
| ▸ | MTOR | P42345 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | F2 | P00734 | 1/20 | 0.61 |
| ▸ | F10 | P00742 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30692549 | 0.88 | CBFB (0.78) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL124267 | 0.88 | CBFB (0.78) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL13866538 | 0.84 | NPC1 (0.74) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL30692551 | 0.83 | CBFB (1.00) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL125187 | 0.83 | CBFB (1.00) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL13866537 | 0.82 | NPC1 (0.81) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL4371835 | 0.82 | METAP2 (1.00) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL18025638 | 0.81 | CBFB (0.68) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL10351275 | 0.81 | NPC1 (1.00) | CBFBMETAP2METAP1NPC1RAB9A | |
| SCHEMBL10351278 | 0.81 | NPC1 (0.68) | CBFBMETAP2METAP1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4234760-A1 | FORMULATION COMPRISING 2-SUBSTITUTED BENZIMIDAZOLE OR 2-SUBSTITUTED IMIDAZOLE CORROSION INHIBITORS | Ecolab USA Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-3303654-B1 | 2-SUBSTITUTED BENZIMIDAZOLE CORROSION INHIBITORS | ECOLAB USA INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-11306400-B2 | 2-substituted imidazole and benzimidazole corrosion inhibitors | ECOLAB USA INC. (US) | 2022-04-19 | — | — | US | disclosed |
| CN-107787380-B | 2-substituted imidazole and benzimidazole corrosion inhibitors | 艺康美国股份有限公司 | 2020-10-30 | — | — | CN | disclosed |
| US-20190136387-A1 | 2-Substituted Imidazole and Benzimidazole Corrosion Inhibitors | ECOLAB USA INC. (US) | 2019-05-09 | — | — | US | disclosed |
| US-10202694-B2 | 2-substituted imidazole and benzimidazole corrosion inhibitors | ECOLAB USA INC. (US) | 2019-02-12 | — | — | US | disclosed |
| EP-3303654-A1 | 2-SUBSTITUTED IMIDAZOLE AND BENZIMIDAZOLE CORROSION INHIBITORS | Ecolab Usa Inc. (US) | 2018-04-11 | — | — | EP | disclosed |
| US-20160348252-A1 | 2-Substituted Imidazole and Benzimidazole Corrosion Inhibitors | ECOLAB USA INC. (US) | 2016-12-01 | — | — | US | disclosed |
| CN-105481944-A | Benzimidazole derivative dipeptide copper complex, and preparation method and applications thereof | UNIV SOUTH CHINA AGRICULT | 2016-04-13 | — | — | CN | disclosed |
| US-20110269071-A1 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, CHEMICAL AMPLIFICATION RESIST COMPOSITION, AND RESIST FILM AND PATTERN FORMING METHOD USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2011-11-03 | — | — | US | disclosed |
| US-7655688-B2 | Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-02-02 | — | — | US | disclosed |
| US-7655688-B2 | Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160348252-A1 | 2-Substituted Imidazole and Benzimidazole Corrosion Inhibitors | TMBIM6, AZI2, BAK1 | CBFB 781/4885METAP2 1077/4885METAP1 1981/4885 |
| US-20190136387-A1 | 2-Substituted Imidazole and Benzimidazole Corrosion Inhibitors | TMBIM6, AZI2, BAK1 | CBFB 781/4885METAP2 1077/4885METAP1 1981/4885 |
| US-10202694-B2 | 2-substituted imidazole and benzimidazole corrosion inhibitors | TMBIM6, AZI2, BAK1 | CBFB 781/4885METAP2 1077/4885METAP1 1981/4885 |
| US-11306400-B2 | 2-substituted imidazole and benzimidazole corrosion inhibitors | TMBIM6, AZI2, BAK1 | CBFB 781/4885METAP2 1077/4885METAP1 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.